THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and FGFR1-Wildtype in Female Patients with Squamous Cell Carcinoma of the Lung

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Jul 14

PMID 37445817

Authors

Fidelis Andrea Flockerzi

Johannes Hohneck

Frank Langer

Rainer Maria Bohle

Phillip Rolf Stahl

Affiliations

Soon will be listed here.

Abstract

Lung cancer is the leading cause of cancer-related deaths in the western world, with squamous cell carcinoma being one of the most common histological subtypes. Prognostic and predictive markers are still largely missing for squamous cell carcinoma of the lung (LSCC). Several studies indicate that THSD7A might at least play a role in the prognosis of different tumors. FAK seems to play an important role in lung cancer and is discussed as a potential therapeutic target. In addition, there is evidence that FAK-dependent signaling pathways might be affected by THSD7A. For that reason, we investigated the role of THSD7A as a potential tumor marker in LSCC and whether THSD7A expression has an impact on the expression level of FAK. A total of 101 LSCCs were analyzed by immunohistochemistry using tissue microarrays. THSD7A positivity was associated with poor overall survival in female patients and showed a relation to high FAK expression in this subgroup. To our knowledge, we are the first to report these correlations in lung cancer. The results might be proof of the assumed activation of FAK-dependent signaling pathways by THSD7A and that as a membrane-associated protein, THSD7A might serve as a putative therapeutic target in LSCC.

Citing Articles

The Role of SCARA5 as a Potential Biomarker in Squamous Cell Carcinoma of the Lung.

Flockerzi F, Hohneck J, Langer F, Trankenschuh W, Stahl P Int J Mol Sci. 2024; 25(13).

PMID: 39000462 PMC: 11242384. DOI: 10.3390/ijms25137355.

Specific antigens in malignancy-associated membranous nephropathy.

Hu X, Wang G, Cheng H Front Med (Lausanne). 2024; 11:1368457.

PMID: 38686366 PMC: 11056512. DOI: 10.3389/fmed.2024.1368457.

References

Du C, Zheng Z, Li D, Chen L, Li N, Yi X . BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK. Oncotarget. 2016; 7(26):40174-40188. PMC: 5130001. DOI: 10.18632/oncotarget.9559. View

Ji H, Pang D, Fu S, Jin Y, Yao L, Qi J . Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer. J Cancer Res Clin Oncol. 2012; 139(3):429-35. DOI: 10.1007/s00432-012-1342-8. View

Wang C, Su P, Du X, Kuo M, Lin C, Yang C . Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J Cell Physiol. 2009; 222(3):685-94. DOI: 10.1002/jcp.21990. View

Miao J, Liu R, Zhou J, Meng S . Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer. Chin Med J (Engl). 2016; 129(23):2868-2872. PMC: 5146797. DOI: 10.4103/0366-6999.194649. View

Wang B, Qi X, Li D, Feng M, Meng X, Fu S . Expression of pY397 FAK promotes the development of non-small cell lung cancer. Oncol Lett. 2016; 11(2):979-983. PMC: 4733957. DOI: 10.3892/ol.2015.3992. View

Ahmad M, Nongmaithem S, Krishnaveni G, Fall C, Yajnik C, Chandak G . Lack of replication of association of THSD7A with obesity. Int J Obes (Lond). 2016; 40(4):725-6. DOI: 10.1038/ijo.2016.15. View

Oishi M, Munesue S, Harashima A, Nakada M, Yamamoto Y, Hayashi Y . Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma. Cancer Med. 2020; 9(11):3904-3917. PMC: 7286445. DOI: 10.1002/cam4.3032. View

Pacini L, Jenks A, Lima N, Huang P . Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer. Cells. 2021; 10(5). PMC: 8151052. DOI: 10.3390/cells10051154. View

Canel M, Secades P, Rodrigo J, Cabanillas R, Herrero A, Suarez C . Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clin Cancer Res. 2006; 12(11 Pt 1):3272-9. DOI: 10.1158/1078-0432.CCR-05-1583. View

10.

Chang M, Wu S, Yang S, Wu C, Wang C, Huang B . FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer. Transl Oncol. 2021; 14(11):101208. PMC: 8390529. DOI: 10.1016/j.tranon.2021.101208. View

11.

Wang C, Chen I, Kuo M, Su P, Lai Z, Wang C . Zebrafish Thsd7a is a neural protein required for angiogenic patterning during development. Dev Dyn. 2011; 240(6):1412-21. DOI: 10.1002/dvdy.22641. View

12.

Tomas N, Beck Jr L, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G . Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014; 371(24):2277-2287. PMC: 4278759. DOI: 10.1056/NEJMoa1409354. View

13.

Xu Q, Zou G, Zhuo L, Gao H, Li W . Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report. Front Oncol. 2022; 12:1002155. PMC: 9557101. DOI: 10.3389/fonc.2022.1002155. View

14.

Halder J, Lin Y, Merritt W, Spannuth W, Nick A, Honda T . Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res. 2007; 67(22):10976-83. DOI: 10.1158/0008-5472.CAN-07-2667. View

15.

Ocak S, Chen H, Callison C, Gonzalez A, Massion P . Expression of focal adhesion kinase in small-cell lung carcinoma. Cancer. 2011; 118(5):1293-301. PMC: 3673887. DOI: 10.1002/cncr.26382. View

16.

Zhang X, Liu Y, Fan C, Wang L, Li A, Zhou H . Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway. Oncotarget. 2017; 8(43):75102-75113. PMC: 5650404. DOI: 10.18632/oncotarget.20527. View

17.

Krook M, Reeser J, Ernst G, Barker H, Wilberding M, Li G . Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer. 2020; 124(5):880-892. PMC: 7921129. DOI: 10.1038/s41416-020-01157-0. View

18.

Xian L, Dong D, Luo J, Zhuo L, Li K, Zhang P . Expression of THSD7A in neoplasm tissues and its relationship with proteinuria. BMC Nephrol. 2019; 20(1):332. PMC: 6708223. DOI: 10.1186/s12882-019-1489-5. View

19.

Chen M, Zhang L, Zhong W, Zheng K, Ye W, Wang M . Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient. Front Immunol. 2021; 12:619147. PMC: 8141750. DOI: 10.3389/fimmu.2021.619147. View

20.

Schildhaus H, Nogova L, Wolf J, Buettner R . FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications. Transl Lung Cancer Res. 2015; 2(2):92-100. PMC: 4369858. DOI: 10.3978/j.issn.2218-6751.2013.03.03. View